T. Geiser (Bern, Switzerland), O. Eickelberg (Munich, Germany)
Late Breaking Abstract: Molecular phenotyping of asthma: Airflow obstruction and loss of asthma control with viral upper respiratory tract infections (URI) as characteristics of "TH2-high" asthma K. Wong McGrath, P. Woodruff, O. Solberg, L. Hou, J. Peng, J. Fahy (San Francisco, United States Of America)
| |
Disturbed hypoxic-angiogenic signalling mediating muscle cachexia in COPD S. M. Abdel-Halim, K. Piehl-Aulin, A. Sirsjö (Uppsala, Örebro, Stockholm, Sweden)
| |
Increased adipose tissue expression of proinflammatory CD40, MKK4 and JNK in patients with very severe COPD R. Tkacova, J. Ukropec, P. Skyba, B. Ukropcova, P. Pobeha, T. Kurdiova, P. Joppa, I. Klimes, I. Tkac, D. Gasperikova (Kosice, Bratislava, Slovakia)
| |
Dysregulated ECM stability: A pathomechanism in chronic obstructive pulmonary disease? N. Kneidinger, A. Nave, G. Kwapiszewska, C. Vogelmeier, W. Seeger, R. Morty (Giessen, Marburg, Germany)
| |
Eight-week endurance training enhances nitroso-redox equilibrium in COPD patients D. A. Rodriguez, J. Roca, M. Cascante, F. Falciani, D. Maier, S. Kalko, N. Turan, V. Selivanov, E. Barreiro (Barcelona, Birmingham, Spain; Martinsried, Germany)
| |
A polymorphism in the gene for mast cell chymase encodes an inactive form of the enzyme and is associated with reduced severity of atopy in asthmatics A. Fawzy, T. Iwanaga, A. R. McEuen, A. Mochizuki, J. W. Holloway, A. F. Walls (Southampton, United Kingdom)
| |
Vascular remodelling in pulmonary hypertension: A role for matrix cross-linking? A. Nave, N. Kneidinger, G. Kwapiszewska, W. Seeger, R. Morty (Giessen, Germany)
| |
The VIP gene is a dominant modulator of the pulmonary circulation S. Said, S. Hamidi (Northport, United States Of America)
| |